𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis

✍ Scribed by Catherine M. T. Sherwin; Sofia Svahn; Antje Van Der Linden; Roland S. Broadbent; Natalie J. Medlicott; David M. Reith

Publisher
Springer
Year
2009
Tongue
English
Weight
308 KB
Volume
65
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic–pharmacodynamic analysis
Pharmacokinetic–pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats
✍ Hisakazu Ohtani; Hitoshi Sato; Tatsuji Iga; Hajime Kotaki; Yasufumi Sawada 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Ebastine (EBS), a novel nonsedative antiallergic agent, is similar to terfenadine in its chemical structure. However, clinical arrhythmogenicity of EBS remains controversial. In this study, we evaluated the possible arrhythmogenic potency of EBS as assessed by QT prolongation from a pharmacokinetic-

A novel three-dose regimen of daclizumab
A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: A pharmacokinetic and pharmacodynamic study
✍ W. Kenneth Washburn; Lewis W. Teperman; Thomas G. Heffron; David D. Douglas; Ste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

This study evaluated the pharmacokinetics and pharmacodynamics of a novel 3-dose regimen of daclizumab in de novo hepatitis C liver transplant recipients. In 30 of 156 recipients receiving daclizumab, mycophenolate mofetil, tacrolimus, and no steroids (Arm 3 of Hep C 3 Liver Study), daclizumab (2, 2